Bringing the fundamentals into focus…
Back to Xenon Pharmaceuticals Inc.
How Xenon Pharmaceuticals Inc. stacks up
XENE · against 263 other Healthcare companies of similar size
Growth
6/ 100
Near the bottom of its peers.
Ranked #255 of 264 · scores higher than 3% of peers
Bars: peers in each 10-point band of the growth score18 peers with a growth score of 0–9, including XENE · Click a bar to see the companies
Why growth scores 6?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth, 3-year revenue growth and earnings per share growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 100% of peers. Revenue growth: -100.0% vs peer median 6.1%
- slower revenue growth over three years: weaker than 85% of peers. 3-year revenue growth: -7.4% vs peer median 5.8%
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = XENE, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | XENE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 263 reported | -100.0% | 8.0% | 0% | 33% | |
| Earnings per share growthHigher is better · 168 reported | Not reported | 11.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 258 reported | -7.4% | 8.7% | 11% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around XENE| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 250 | 2.4B USD | 8 | 20 | |
| 250 | 3.4B USD | 8 | 55 | |
| 254 | 24.9B CNY (≈$3.5B) | 7 | 38 | |
| 255 | 14.8B CNY (≈$2.1B) | 6 | 23 | |
| 255 | 3.7B USD | 6 | 28 | |
| 257 | 17.6B CNY (≈$2.5B) | 5 | 11 | |
| 257 | 4.8B USD | 5 | 27 | |
| 257 | 4.6B USD | 5 | 29 | |
| 260 | 31.0B CNY (≈$4.3B) | 4 | 26 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score